Skip to main content

Pfizer first-quarter results beat expectations despite COVID-19 vaccine sales plunge

New product launches expected to accelerate non-COVID sales later this year
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.